Dextromethorphan Hydrobromide (DMR) is a premium-grade, white to off-white crystalline powder classified as an active pharmaceutical ingredient (API). Manufactured by reputed producers in India and packaged in a secure 25 kg drum, this compound is a synthetic, non-opioid derivative of the morphinan class of alkaloids, related to codeine but devoid of analgesic or addictive properties.
As a potent, non-narcotic cough suppressant (antitussive), this compound exhibits its therapeutic activity by crossing the blood-brain barrier. It depresses the medullary cough center in the central nervous system by acting as a sigma-1 receptor agonist and NMDA receptor antagonist, elevating the threshold for coughing and effectively interrupting the transmission of cough impulses. It also functions as a non-opioid, centrally-acting drug with a low potential for abuse, making it a gold-standard ingredient for modern OTC pharmaceutical products.
This versatile API is primarily used in the mass production of over-the-counter medications, syrups, liquid formulations, and solid dosage forms for the temporary relief of dry, non-productive cough caused by the common cold, flu, or inhaled irritants. It is also incorporated into combination products with decongestants and antihistamines for comprehensive symptom relief, utilized in the development of sustained-release pharmaceutical formulations, and employed in antitussive research exploring potential neuroprotective effects and broader therapeutic applications.
Sourced from reliable Indian manufacturers, this DMR API meets rigorous purity specifications. The 25 kg drum is hermetically sealed for industrial protection. It is a trusted raw material for pharmaceutical R&D departments, generic drug manufacturers, contract manufacturing organizations (CMOs), and large-scale healthcare product producers requiring a consistent, reliable efficacy, and high-grade central antitussive API.












